BACKGROUND: Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in directing surgical management. This study investigated the use of quantitative computed tomography (CT) features to preoperatively assess survival for pancreatic ductal adenocarcinoma (PDAC) patients. METHODS: A prospectively maintained database identified consecutive chemotherapy-naive patients with CT angiography and resected PDAC between 2009 and 2012. Variation in CT enhancement patterns was extracted from the tumor region using texture analysis, a quantitative image analysis tool previously described in the literature. Two continuous survival models were constructed, with 70% of the data (training set) using Cox regression, first based only on preoperative serum cancer antigen (CA) 19-9 levels and image features (model A), and then on CA19-9, image features, and the Brennan score (composite pathology score; model B). The remaining 30% of the data (test set) were reserved for independent validation. RESULTS: A total of 161 patients were included in the analysis. Training and test sets contained 113 and 48 patients, respectively. Quantitative image features combined with CA19-9 achieved a c-index of 0.69 [integrated Brier score (IBS) 0.224] on the test data, while combining CA19-9, imaging, and the Brennan score achieved a c-index of 0.74 (IBS 0.200) on the test data. CONCLUSION: We present two continuous survival prediction models for resected PDAC patients. Quantitative analysis of CT texture features is associated with overall survival. Further work includes applying the model to an external dataset to increase the sample size for training and to determine its applicability.
BACKGROUND:Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in directing surgical management. This study investigated the use of quantitative computed tomography (CT) features to preoperatively assess survival for pancreatic ductal adenocarcinoma (PDAC) patients. METHODS: A prospectively maintained database identified consecutive chemotherapy-naive patients with CT angiography and resected PDAC between 2009 and 2012. Variation in CT enhancement patterns was extracted from the tumor region using texture analysis, a quantitative image analysis tool previously described in the literature. Two continuous survival models were constructed, with 70% of the data (training set) using Cox regression, first based only on preoperative serum cancer antigen (CA) 19-9 levels and image features (model A), and then on CA19-9, image features, and the Brennan score (composite pathology score; model B). The remaining 30% of the data (test set) were reserved for independent validation. RESULTS: A total of 161 patients were included in the analysis. Training and test sets contained 113 and 48 patients, respectively. Quantitative image features combined with CA19-9 achieved a c-index of 0.69 [integrated Brier score (IBS) 0.224] on the test data, while combining CA19-9, imaging, and the Brennan score achieved a c-index of 0.74 (IBS 0.200) on the test data. CONCLUSION: We present two continuous survival prediction models for resected PDACpatients. Quantitative analysis of CT texture features is associated with overall survival. Further work includes applying the model to an external dataset to increase the sample size for training and to determine its applicability.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2012-07-04 Impact factor: 3.452
Authors: Thida Win; Kenneth A Miles; Sam M Janes; Balaji Ganeshan; Manu Shastry; Raymondo Endozo; Marie Meagher; Robert I Shortman; Simon Wan; Irfan Kayani; Peter J Ell; Ashley M Groves Journal: Clin Cancer Res Date: 2013-05-09 Impact factor: 12.531
Authors: Soon Ho Yoon; Jeong Min Lee; Jae Yoon Cho; Kyung Bun Lee; Ji Eun Kim; Seung Kyoung Moon; Soo Jin Kim; Jee Hyun Baek; Seung Ho Kim; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi Journal: Radiology Date: 2011-03-15 Impact factor: 11.105
Authors: Jin Hee Kim; Seong Ho Park; Eun Sil Yu; Myung-Hwan Kim; Jihun Kim; Jae Ho Byun; Seung Soo Lee; Hye Jeon Hwang; Jae-Yeon Hwang; Sang Soo Lee; Moon-Gyu Lee Journal: Radiology Date: 2010-08-09 Impact factor: 11.105
Authors: Cristina R Ferrone; Murray F Brennan; Mithat Gonen; Daniel G Coit; Yuman Fong; Sun Chung; Laura Tang; David Klimstra; Peter J Allen Journal: J Gastrointest Surg Date: 2007-11-20 Impact factor: 3.452
Authors: Marc A Attiyeh; Jayasree Chakraborty; Lior Gazit; Liana Langdon-Embry; Mithat Gonen; Vinod P Balachandran; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham; Peter J Allen; Richard K Do; Amber L Simpson Journal: HPB (Oxford) Date: 2018-08-07 Impact factor: 3.647
Authors: Ameya Kulkarni; Ivan Carrion-Martinez; Nan N Jiang; Srikanth Puttagunta; Leyo Ruo; Brandon M Meyers; Tariq Aziz; Christian B van der Pol Journal: Eur Radiol Date: 2020-01-17 Impact factor: 5.315